Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
E

Deficiencies in Controlled Substance Accountability and Medication Availability

Sacramento, California Survey Completed on 05-08-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure accurate documentation and accountability of controlled substances for a resident with a physician's order for tramadol. There were discrepancies between the Controlled Drug Record (CDR) and the Medication Administration Record (MAR), with instances where medication was removed from the cart but not documented on the MAR, and vice versa. Both the licensed nurse and the Director of Nursing confirmed that facility policy required documentation on both records immediately after administration, and that these discrepancies were present for the resident in question. Additionally, the facility did not consistently obtain signatures from both off-going and on-coming nurses on the controlled drug shift-to-shift count records for multiple medication carts. Several shifts were missing required signatures, which are necessary to confirm that controlled medication counts were completed and that no discrepancies were identified during shift changes. Both nursing staff and the Director of Nursing acknowledged that this was not in accordance with facility policy, which mandates special handling and record keeping for controlled substances. The facility also failed to replace a narcotic emergency kit (e-kit) in a timely manner after it was opened, as required by policy. The opened kit was found with a red plastic tie and logs indicating medication had been removed, but the kit had not been reordered from the pharmacy. Furthermore, a resident with diabetes did not receive a scheduled dose of Ozempic because the medication was pending delivery from the pharmacy, and there was no documentation that the family had been contacted to supply the medication, despite the expectation that such communication should occur and be documented.

An unhandled error has occurred. Reload 🗙